Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Junghoan Park, Jeong Min Lee, Tae-Hyung Kim, Jeong Hee Yoon

Clin Mol Hepatol. 2022;28(3):362-379. Published online December 27, 2021

DOI: https://doi.org/10.3350/cmh.2021.0361

View: 5689 Download: 224 Web of Science: 15 Crossref: 17

Ibrahim A. Hanouneh, Naim Alkhouri, Amit G. Singal

Clin Mol Hepatol. 2019;25(3):264-269. Published online March 4, 2019

DOI: https://doi.org/10.3350/cmh.2019.1001

View: 9579 Download: 324 Web of Science: 47 Crossref: 47

So Hyun Park, So Yeon Kim, Chong Hyun Suh, Seung Soo Lee, Kyoung Won Kim, So Jung Lee, Moon-Gyu Lee

Clin Mol Hepatol. 2016;22(3):406-414. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0106

View: 12439 Download: 280 Web of Science: 38 Crossref: 40

Woo Jung Choi, Woo Kyoung Jeong, Yongsoo Kim, Jinoo Kim, Ju Yeon Pyo, Young Ha Oh

Clin Mol Hepatol. 2012;18(1):101-104. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.101

View: 8027 Download: 59 Crossref: 6

Jeong Il Jeong, Kwang Hyub Han, Byung Hyun Choe, Sang Hoon Ahn, Dong Ki Kim, Chung Mo Nam, Jae Bock Chung, Chae Yoon Chon and Young Myoung Moon

Clin Mol Hepatol. 1998;4(4):330-345. Published online January 1, 2000

View: 2089 Download: 17

1 |

Viewed By 5333	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5281	MAFLD: How is it different from NAFLD?
Viewed By 5163	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3875	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3824	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search